Mersana Therapeutics Inc (MRSN)

01:34 AM

MRSN (Mersana Therapeutics Inc) may reap gains as insiders became active recently - knoxdaily.com

01:34 AM

09:17 AM

Holdings of Mersana Therapeutics Inc (MRSN) are aligned with the stars - Sete News

09:17 AM

Apr 28, 2025

Investors’ Faith in Mersana Therapeutics Inc (MRSN) could reap rewards if they hold on for the long haul - uspostnews.com

Apr 28, 2025

Apr 28, 2025

Investor’s Delight: Mersana Therapeutics Inc (MRSN) Closes Strong at 0.36, Up 0.44 - DWinneX

Apr 28, 2025

Apr 28, 2025

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Stock Holdings Lifted by Geode Capital Management LLC - Defense World

Apr 28, 2025

Apr 25, 2025

MRSN Shares Experience Decline in Value - knoxdaily.com

Apr 25, 2025

Apr 25, 2025

Mersana therapeutics VP Mandelia sells $1,128 in stock - MSN

Apr 25, 2025

Apr 23, 2025

Mersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual Meeting | MRSN Stock News - GuruFocus

Apr 23, 2025

Apr 23, 2025

Mersana Therapeutics Announces Presentations on Emiltatug Ledadotin at ASCO 2025 Annual Meeting - Nasdaq

Apr 23, 2025

Apr 23, 2025

Mersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual Meeting - GlobeNewswire

Apr 23, 2025

Apr 23, 2025

Breakthrough Cancer Drug Emi-Le Earns Dual FDA Fast Track Status: Key Data Coming at ASCO 2025 - Stock Titan

Apr 23, 2025

Apr 23, 2025

Daily Market Movement: Mersana Therapeutics Inc (MRSN) Sees a 15.02 Increase, Closing at 0.38 - DWinneX

Apr 23, 2025

Apr 23, 2025

Mersana Therapeutics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - investchronicle.com

Apr 23, 2025

Apr 23, 2025

It makes sense and dollars to buy Mersana Therapeutics Inc (MRSN) stock - Sete News

Apr 23, 2025

Apr 22, 2025

Mersana Therapeutics Inc [MRSN] Insider Activity: An Update for Investors - knoxdaily.com

Apr 22, 2025

Apr 14, 2025

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Shares Sold by Wellington Management Group LLP - Defense World

Apr 14, 2025

Apr 13, 2025

Sei Investments Co. Purchases Shares of 69,527 Mersana Therapeutics, Inc. (NASDAQ:MRSN) - Defense World

Apr 13, 2025

Apr 08, 2025

Trial misses sink cancer stocks in Q1: Mersana, Cargo, Mural fall - BioWorld MedTech

Apr 08, 2025

Apr 05, 2025

Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Apr 05, 2025

Apr 04, 2025

MRSN stock touches 52-week low at $0.3 amid sharp annual decline - Investing.com

Apr 04, 2025

Apr 04, 2025

Mersana Strengthens Team with Strategic 26,790-Share RSU Grant to New Hire - Stock Titan

Apr 04, 2025

Apr 04, 2025

MRSN stock touches 52-week low at $0.3 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 02, 2025

When Would Be The Best Time To Buy Mersana Therapeutics Inc (NASDAQ: MRSN) Stock? - stocksregister.com

Apr 02, 2025

Apr 01, 2025

Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress - The Manila Times

Apr 01, 2025

Apr 01, 2025

Mersana Therapeutics Announces Upcoming Oral Presentation - GlobeNewswire

Apr 01, 2025

Apr 01, 2025

FDA Fast-Tracked Breast Cancer Drug Shows Promise: Key Clinical Data Coming at ESMO 2025 - Stock Titan

Apr 01, 2025

Mar 28, 2025

Critical Contrast: Mersana Therapeutics (NASDAQ:MRSN) & Opus Genetics (NASDAQ:IRD) - Defense World

Mar 28, 2025

Mar 27, 2025

MRSN stock plunges to 52-week low of $0.37 amid market challenges - Investing.com India

Mar 27, 2025

Mar 27, 2025

MRSN stock plunges to 52-week low of $0.37 amid market challenges By Investing.com - Investing.com South Africa

Mar 27, 2025

Mar 27, 2025

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough - simplywall.st

Mar 27, 2025

Mar 21, 2025

Drug developers show mixed performance in early 2025 - BioWorld MedTech

Mar 21, 2025

Mar 20, 2025

MRSN stock touches 52-week low at $0.43 amid sharp decline - Investing.com India

Mar 20, 2025

Mar 13, 2025

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Mar 13, 2025

Mar 11, 2025

MRSN stock plunges to 52-week low of $0.45 amid market challenges - Investing.com Australia

Mar 11, 2025

Mar 11, 2025

Mersana at Leerink Global Healthcare Conference: Strategic ADC Insights By Investing.com - Investing.com Canada

Mar 11, 2025

Mar 11, 2025

MRSN stock plunges to 52-week low of $0.45 amid market challenges By Investing.com - Investing.com South Africa

Mar 11, 2025

Mar 10, 2025

Q1 EPS Estimates for Mersana Therapeutics Lowered by Wedbush - MarketBeat

Mar 10, 2025

Mar 08, 2025

Industry Analysts Just Made A Meaningful Upgrade To Their Mersana Therapeutics, Inc. (NASDAQ:MRSN) Revenue Forecasts - Simply Wall St

Mar 08, 2025

Mar 07, 2025

Mersana Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Mar 07, 2025

Q1 EPS Estimate for Mersana Therapeutics Reduced by Analyst - Defense World

Mar 07, 2025

Mar 07, 2025

Brokers Issue Forecasts for MRSN Q1 Earnings - Defense World

Mar 07, 2025

Mar 06, 2025

Earnings Update: Mersana Therapeutics, Inc. (NASDAQ:MRSN) Just Reported And Analysts Are Boosting Their Estimates - Yahoo Finance

Mar 06, 2025

Mar 05, 2025

Industry Analysts Just Made A Captivating Upgrade To Their Mersana Therapeutics, Inc. (NASDAQ:MRSN) Revenue Forecasts - Yahoo Finance

Mar 05, 2025

Mar 04, 2025

Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Tops Revenue Estimates - MSN

Mar 04, 2025

Mar 04, 2025

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 04, 2025

Mar 04, 2025

Mersana Therapeutics Inc (MRSN) Q4 2024 Earnings Call Highlights: Strategic Advances and ... - Yahoo Finance

Mar 04, 2025